See also this year's filing and all EDGAR filings for this company.
PDF Report 0001498068_2018_American_Renal_Associates_Holdings_Inc.pdf
Logs
| warning | Similarly named company. Duplicate? | None | {'details': [{'other_company': 'AMERICAN INTERNATIONAL HOLDINGS CORP.', 'shared_tokens': {'american'}}]} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001498068')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001498068, American Renal Associates Holdings Inc.
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 598,795,000 |
| 1 | AssetsNonCurrent | 9,285,000 |
| 2 | AssetsCurrent | 187,591,000 |
| 3 | PropertyPlantAndEquipment | 168,537,000 |
| 4 | remainder_Assets | 0 |
| 5 | LongTermLiabilities | 530,434,000 |
| 6 | LiabilitiesCurrent | 165,894,000 |
| 7 | remainder_Liabilities | 7,500,000 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 102,598,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 37,634,000 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 0 |
| 16 | remainder_Expenses | 506,610,000 |
| 17 | remainder_Revenues | 7,234,000 |
| 18 | remainder_NetIncome | 715,291,000 |
| 19 | remainder_ComprehensiveNetIncome | -71,403,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 964,208,000 |
| 1 | Liabilities | 703,828,000 |
| 2 | Expenses | 646,842,000 |
| 3 | Revenues | 7,234,000 |
| 4 | StockholdersEquity | 260,380,000 |
| 5 | NetIncome | 75,683,000 |
| 6 | ComprehensiveNetIncome | 4,280,000 |
| 7 | BaseVar | 1,792,130,050 |
| 8 | EconomicCapitalRatio | 0.534 |
Edgar->Model Mapping
Feature Distribution
Change over Time
